Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
NEARLY HALF OF U.S. HOUSE MEMBERS OPPOSE MOVE TO CONVERT 340B INTO A REBATE PROGRAM
-
STATEMENT REGARDING NOVARTIS CUTTING OFF ACCESS TO 340B PRICING THROUGH COMMUNITY-BASED PHARMACIES
-
COMMENT LETTER TO CMS CALLS FOR SCRAPPING PROPOSAL TO DEEPEN MEDICARE CUTS TO 340B HOSPITALS IN 2021
-
STATEMENT ON ASTRAZENECA AND SANOFI DENIALS OF 340B PRICING TO SAFETY-NET HOSPITALS
-
BIPARTISAN GROUP OF U.S. SENATORS CALLS FOR HHS ACTION AGAINST UNLAWFUL MANUFACTURER PRICING POLICIES
-
MORE THAN HALF OF U.S. HOUSE BACKS 340B HOSPITALS IN CALLING ON HHS TO STOP UNLAWFUL MANUFACTURER PRICING BEHAVIOR
-
MORE THAN 1,100 HOSPITALS URGE HHS TO HALT ATTEMPTS TO UNDERMINE THE 340B DRUG PRICING PROGRAM
-
STATEMENT ON ELI LILLY CUTTING OFF ALL ACCESS TO 340B PRICING THROUGH COMMUNITY-BASED PHARMACIES
-
7 Groups Representing Hospitals and Pharmacists Ask Azar to Enforce 340B Rules
-
STATEMENT ON ASTRAZENECA CUTTING OFF ACCESS TO 340B DISCOUNTED PRICING THROUGH CONTRACT PHARMACIES
-
STATEMENT ON PROPOSED MEDICARE PAYMENT CUTS TO 340B HOSPITALS IN 2021
-
Federal Drug Discounts Provide Stability Amid Crisis